218 related articles for article (PubMed ID: 23159831)
21. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
22. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
Zhang X; Andren PE; Svenningsson P
Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622
[TBL] [Abstract][Full Text] [Related]
23. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons.
van den Munckhof P; Luk KC; Ste-Marie L; Montgomery J; Blanchet PJ; Sadikot AF; Drouin J
Development; 2003 Jun; 130(11):2535-42. PubMed ID: 12702666
[TBL] [Abstract][Full Text] [Related]
24. Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.
Peng C; Aron L; Klein R; Li M; Wurst W; Prakash N; Le W
J Neurosci; 2011 Sep; 31(36):12802-15. PubMed ID: 21900559
[TBL] [Abstract][Full Text] [Related]
25. Anatomical and functional reconstruction of the nigrostriatal system in vitro: selective innervation of the striatum by dopaminergic neurons.
Becq H; Bosler O; Geffard M; Enjalbert A; Herman JP
J Neurosci Res; 1999 Nov; 58(4):553-66. PubMed ID: 10533047
[TBL] [Abstract][Full Text] [Related]
26. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.
Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719
[TBL] [Abstract][Full Text] [Related]
27. Alterations in serotonin receptors in the neostriatum of weaver mutant mice.
Dewar KM
Neurochem Res; 1999 Nov; 24(11):1449-54. PubMed ID: 10555786
[TBL] [Abstract][Full Text] [Related]
28. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
29. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
Bishop C; Daut GS; Walker PD
Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
[TBL] [Abstract][Full Text] [Related]
30. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
[TBL] [Abstract][Full Text] [Related]
31. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
De Deurwaerdère P; Spampinato U
J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
[TBL] [Abstract][Full Text] [Related]
32. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons.
Chung S; Hedlund E; Hwang M; Kim DW; Shin BS; Hwang DY; Kang UJ; Isacson O; Kim KS
Mol Cell Neurosci; 2005 Feb; 28(2):241-52. PubMed ID: 15691706
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy.
Yeghiayan SK; Kelley AE
Pharmacol Biochem Behav; 1995 Nov; 52(3):493-501. PubMed ID: 8545465
[TBL] [Abstract][Full Text] [Related]
34. Impaired motor coordination in Pitx3 overexpression mice.
Kim H; Quan X; Seong Y; Kim J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
[TBL] [Abstract][Full Text] [Related]
35. Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.
Wang Y; Zhou FM
Front Pharmacol; 2017; 8():935. PubMed ID: 29311936
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice.
Sarhan H; Grimaldi B; Hen R; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):12-8. PubMed ID: 10651141
[TBL] [Abstract][Full Text] [Related]
37. Pitx3 is required for development of substantia nigra dopaminergic neurons.
Nunes I; Tovmasian LT; Silva RM; Burke RE; Goff SP
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4245-50. PubMed ID: 12655058
[TBL] [Abstract][Full Text] [Related]
38. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
[TBL] [Abstract][Full Text] [Related]
40. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]